EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 317 filers reported holding EDITAS MEDICINE INC in Q2 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $98,000 | -62.5% | 8,040 | -63.5% | 0.01% | -50.0% |
| Q2 2022 | $261,000 | -37.7% | 22,027 | 0.0% | 0.01% | -29.4% |
| Q1 2022 | $419,000 | +160.2% | 22,027 | +263.4% | 0.02% | +183.3% |
| Q4 2021 | $161,000 | -53.7% | 6,062 | -28.5% | 0.01% | -45.5% |
| Q3 2021 | $348,000 | -36.5% | 8,479 | -12.4% | 0.01% | -15.4% |
| Q2 2021 | $548,000 | +35.0% | 9,678 | 0.0% | 0.01% | +30.0% |
| Q1 2021 | $406,000 | -50.4% | 9,678 | -17.0% | 0.01% | -41.2% |
| Q4 2020 | $818,000 | +132.4% | 11,663 | -6.9% | 0.02% | +112.5% |
| Q3 2020 | $352,000 | +15.4% | 12,534 | +21.4% | 0.01% | +14.3% |
| Q2 2020 | $305,000 | +36.8% | 10,324 | -8.2% | 0.01% | +40.0% |
| Q1 2020 | $223,000 | -44.0% | 11,246 | -16.4% | 0.01% | -44.4% |
| Q4 2019 | $398,000 | +30.1% | 13,448 | 0.0% | 0.01% | +28.6% |
| Q3 2019 | $306,000 | -16.8% | 13,448 | -9.7% | 0.01% | -12.5% |
| Q2 2019 | $368,000 | +7.6% | 14,890 | +55.9% | 0.01% | 0.0% |
| Q2 2018 | $342,000 | – | 9,551 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NIA IMPACT ADVISORS, LLC | 54,615 | $4,897,000 | 2.55% |
| Capital Impact Advisors, LLC | 130,000 | $9,114,000 | 2.24% |
| ARK Investment Management | 10,125,564 | $709,903,000 | 1.89% |
| Nikko Asset Management Americas, Inc. | 4,388,143 | $307,653,000 | 1.75% |
| Spectrum Planning & Advisory Services Inc. | 17,522 | $1,228,000 | 1.32% |
| DDD Partners, LLC | 79,527 | $5,576,000 | 1.10% |
| Brevan Howard Capital Management LP | 76,420 | $5,358,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 538,721 | $37,770,000 | 0.75% |
| DC Investments Management, LLC | 3,627 | $254,000 | 0.63% |
| Haafor (Singapore) Pte. Ltd. | 4,761 | $334,000 | 0.62% |